Hangzhou-based Well-healthcare develops monitoring systems and tumor liquid biopsy products for diagnostics.
Established in 2016 and based in Hangzhou, China, Well-healthcare Technologies Co. focuses on research and development of monitoring systems and tumor liquid biopsy products. Its main products include the Bio-pSi mass spectrometry kit, the Clin-MS Plat high-throughput mass spectrometer and the Huijian Zhiyun AI diagnostic software. The company set up subsidiary Zhejiang Huijian Zhipu Technology in 2018 and completed pilot-scale development of a bowel cancer peptide mapping test kit in 2020. It is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in